Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 spike N-terminal domain modulates TMPRSS2-dependent viral entry and fusogenicity
Bo Meng, Rawlings Datir, Jinwook Choi, et al.
Cell Reports (2022) Vol. 40, Iss. 7, pp. 111220-111220
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

SARS-CoV-2 variant biology: immune escape, transmission and fitness
Alessandro M. Carabelli, Thomas P. Peacock, Lucy Thorne, et al.
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 989
SARS-CoV-2 biology and host interactions
Silvio Steiner, Annika Kratzel, G. Tuba Barut, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 4, pp. 206-225
Closed Access | Times Cited: 81
Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2
Bingjie Hu, Jasper Fuk‐Woo Chan, Huan Liu, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2275-2287
Open Access | Times Cited: 72
SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”
Benjamín L. Sievers, Mark T. K. Cheng, Kata Csiba, et al.
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 171-183
Open Access | Times Cited: 51
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants
Amin Addetia, Luca Piccoli, James Brett Case, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 31
High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spike
Timothy J.C. Tan, Zongjun Mou, Ruipeng Lei, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 24
Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through structural plasticity
Pan Liu, Can Yue, Bo Meng, et al.
National Science Review (2024) Vol. 11, Iss. 7
Open Access | Times Cited: 12
Single-molecule imaging reveals allosteric stimulation of SARS-CoV-2 spike receptor binding domain by host sialic acid
Marco A. Díaz-Salinas, Aastha Jain, Natasha D. Durham, et al.
Science Advances (2024) Vol. 10, Iss. 29
Open Access | Times Cited: 9
Evolutionary remodelling of N‐terminal domain loops fine‐tunes SARS‐CoV‐2 spike
Diego Cantoni, Matthew J Murray, Mphatso D. Kalemera, et al.
EMBO Reports (2022) Vol. 23, Iss. 10
Open Access | Times Cited: 34
Receptor-Binding Domain (RBD) Antibodies Contribute More to SARS-CoV-2 Neutralization When Target Cells Express High Levels of ACE2
Ariana Ghez Farrell, Bernadeta Dadonaite, Allison J. Greaney, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 2061-2061
Open Access | Times Cited: 31
Host susceptibility and structural and immunological insight of S proteins of two SARS-CoV-2 closely related bat coronaviruses
Xiuyuan Ou, Ge Xu, Pei Li, et al.
Cell Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 21
AlphaFold2 Reveals Structural Patterns of Seasonal Haplotype Diversification in SARS-CoV-2 Spike Protein Variants
Muhammad Asif Ali, Gustavo Caetano‐Anollés
Biology (2024) Vol. 13, Iss. 3, pp. 134-134
Open Access | Times Cited: 6
Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor N-0385 and synergistic action with direct-acting antivirals
Jimena Pérez‐Vargas, Gabriel Lemieux, Connor A.H. Thompson, et al.
Antiviral Research (2024) Vol. 225, pp. 105869-105869
Open Access | Times Cited: 6
Deep mutagenesis scanning using whole trimeric SARS-CoV-2 spike highlights the importance of NTD-RBD interactions in determining spike phenotype
Ruthiran Kugathasan, Ksenia Sukhova, Maya Moshe, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 8, pp. e1011545-e1011545
Open Access | Times Cited: 13
Therapeutic development targeting host heparan sulfate proteoglycan in SARS-CoV-2 infection
Qi Zhang, Ivan Pavlinov, Yihong Ye, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 5
COVID-19 Biogenesis and Intracellular Transport
Alexander A. Mirоnоv, M.A. Savin, Galina V. Beznoussenko
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4523-4523
Open Access | Times Cited: 12
Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through multiple mechanisms
Pan Liu, Can Yue, Bo Meng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Dual‐Locking the SARS‐CoV‐2 Spike Trimer: An Amphipathic Molecular “Bolt” Stabilizes Conserved Druggable Interfaces for Coronavirus Inhibition
Shiliang Li, Fang Ye, Yucheng Zheng, et al.
Advanced Science (2025)
Open Access
Towards Quantum-Chemical Level Calculations of SARS-CoV-2 Spike Protein Variants of Concern by First Principles Density Functional Theory
W. Y. Ching, Puja Adhikari, Bahaa Jawad, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 517-517
Open Access | Times Cited: 10
Molecular characterization of SARS-CoV-2 Omicron clade and clinical presentation in children
Rossana Scutari, Valeria Fox, Vanessa Fini, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
The accomplices: Heparan sulfates and N-glycans foster SARS-CoV-2 spike:ACE2 receptor binding and virus priming
Giulia Paiardi, Matheus Ferraz, Marco Rusnati, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 43
Open Access | Times Cited: 3
Receptor binding domain (RBD) antibodies contribute more to SARS-CoV-2 neutralization when target cells express high levels of ACE2
Ariana Ghez Farrell, Bernadeta Dadonaite, Allison J. Greaney, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 12
Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responses
Karlijn van der Straten, Denise Guerra, Gius Kerster, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 8, pp. e1012453-e1012453
Open Access | Times Cited: 2
Performance of SARS COV-2 IgG Anti-N as an Independent Marker of Exposure to SARS COV-2 in an Unvaccinated West African Population
Adam Abdullahi, James Opoku Frimpong, Mark T. K. Cheng, et al.
American Journal of Tropical Medicine and Hygiene (2023) Vol. 109, Iss. 4, pp. 890-894
Open Access | Times Cited: 6
SARS-CoV-2 Spike Protein Mutation at Cysteine-488 Impairs Its Golgi Localization and Intracellular S1/S2 Processing
Yuichiro Yamamoto, Tetsuya Inoue, Miyu Inoue, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15834-15834
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top